An Exploratory Study of Systemic Administration of the Toll-Like Receptor-7 Agonist 852A in Patients With Refractory Metastatic Melanoma
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-07-1938
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2008
Authors
Publisher
American Association for Cancer Research (AACR)